"10.1371_journal.pone.0010614","plos one","2010-05-12T00:00:00Z","Svitlana Garbuzova-Davis; Robert L Woods; Michael K Louis; Theresa A Zesiewicz; Nicole Kuzmin-Nichols; Kelly L Sullivan; Amber M Miller; Diana G Hernandez-Ontiveros; Paul R Sanberg","Center of Excellence for Aging and Brain Repair, College of Medicine, University of South Florida, Tampa, Florida, United States of America; Department of Neurosurgery and Brain Repair, College of Medicine, University of South Florida, Tampa, Florida, United States of America; Department of Neurology, College of Medicine, University of South Florida, Tampa, Florida, United States of America; Department of Molecular Pharmacology and Physiology, College of Medicine, University of South Florida, Tampa, Florida, United States of America; Department of Pathology and Cell Biology, College of Medicine, University of South Florida, Tampa, Florida, United States of America; Department of Psychiatry, College of Medicine, University of South Florida, Tampa, Florida, United States of America; Saneron CCEL Therapeutics, Inc., Tampa, Florida, United States of America","Conceived and designed the experiments: SGD PS. Performed the experiments: RLWI MKL TZ KLS AMM DGHO. Analyzed the data: SGD RLWI MKL. Contributed reagents/materials/analysis tools: NKN PS. Wrote the paper: SGD.","SGD is a consultant and PRS is a co-founder of Saneron CCEL Therapeutics, Inc. NK is employed by Saneron CCEL Therapeutics, Inc., is an inventor on some pending patent applications, owns Saneron stock (1.3% ownership stake), and has stock options. This does not alter the adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2010","05","Svitlana Garbuzova-Davis","SGD",9,TRUE,2,6,3,1,TRUE,TRUE,TRUE,1,"2",FALSE
